These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32929920)

  • 1. [Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)].
    Vinnikova MA; Skryabin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):23-26. PubMed ID: 32929920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
    Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
    Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
    Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.
    Yeruva RR; Mekala HM; Sidhu M; Lippmann S
    Innov Clin Neurosci; 2019 Jan; 16(1-2):31-32. PubMed ID: 31037226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychoses in the mentally retarded].
    Sosiukalo OD
    Psychiatr Neurol Med Psychol Beih; 1968; 8-9():63-9. PubMed ID: 5006391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.
    Fusar-Poli P; Cappucciati M; Rutigliano G; Heslin M; Stahl D; Brittenden Z; Caverzasi E; McGuire P; Carpenter WT
    Schizophr Bull; 2016 Nov; 42(6):1395-1406. PubMed ID: 26980142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
    Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
    Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position of affective symptomatology in the course of delusional psychoses.
    Schanda H; Gabriel E
    Psychopathology; 1988; 21(1):1-11. PubMed ID: 3222425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.
    Chang WC; Wong CSM; Chen EYH; Lam LCW; Chan WC; Ng RMK; Hung SF; Cheung EFC; Sham PC; Chiu HFK; Lam M; Lee EHM; Chiang TP; Chan LK; Lau GKW; Lee ATC; Leung GTY; Leung JSY; Lau JTF; van Os J; Lewis G; Bebbington P
    Schizophr Bull; 2017 Oct; 43(6):1280-1290. PubMed ID: 28586480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive psychoses and schizophrenia with good prognosis.
    McCabe MS
    Arch Gen Psychiatry; 1976 May; 33(5):571-6. PubMed ID: 1267573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and schizo-affective psychosis.
    Achté K; Tuulio-Henriksson A
    Psychiatr Clin (Basel); 1983; 16(2-4):126-40. PubMed ID: 6622723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.